Видео ютуба по тегу Claudio Cerchione

Frontline Therapy in Multiple Myeloma | Claudio Cerchione, MD | IMS 2024
Frontline Therapy in Multiple Myeloma | Claudio Cerchione, MD | IMS 2024
Claudio Cerchione on the 2nd SOHO Italy meeting
Claudio Cerchione on the 2nd SOHO Italy meeting
Dott. Claudio Cerchione: Gammopatie Monoclonali e Mieloma Multiplo
Dott. Claudio Cerchione: Gammopatie Monoclonali e Mieloma Multiplo
Dott. Claudio Cerchione: La Rivoluzione nel Trattamento dei Tumori del Sangue
Dott. Claudio Cerchione: La Rivoluzione nel Trattamento dei Tumori del Sangue
Diagnosis and Monitoring Multiple Myeloma | Claudio Cerchione, MD | IMS 2024
Diagnosis and Monitoring Multiple Myeloma | Claudio Cerchione, MD | IMS 2024
ASH 2024 Wrap-Up: What's next in #Myeloma Treatment | Claudio Cerchione, MD | #ASH24
ASH 2024 Wrap-Up: What's next in #Myeloma Treatment | Claudio Cerchione, MD | #ASH24
Claudio Cerchione INSIDE SOHO Italy
Claudio Cerchione INSIDE SOHO Italy
SOHO Italy 2021: what to expect
SOHO Italy 2021: what to expect
Claudio Cerchione tell about the 4th Soho Italy Annual Conference
Claudio Cerchione tell about the 4th Soho Italy Annual Conference
Claudio Cerchione - Agile: phase 3 study of Ivosidenib + Azacitidine vs Placebo + Azacitidine
Claudio Cerchione - Agile: phase 3 study of Ivosidenib + Azacitidine vs Placebo + Azacitidine
The Evolving Landscape of Multiple Myeloma | Claudio Cerchione, MD, PhD | ASH 2023
The Evolving Landscape of Multiple Myeloma | Claudio Cerchione, MD, PhD | ASH 2023
Claudio Cerchione - about the 1st Clinical & Biological school of CAR-T
Claudio Cerchione - about the 1st Clinical & Biological school of CAR-T
Claudio Cerchione, MD, PhD, on Managing Multiple Myeloma in Special Populations of Patients
Claudio Cerchione, MD, PhD, on Managing Multiple Myeloma in Special Populations of Patients
SNEV Video Interview Series: Claudio Cerchione President of SOHO Italy
SNEV Video Interview Series: Claudio Cerchione President of SOHO Italy
Claudio Cerchione -
Claudio Cerchione - "How to integrate CAR-T in the current clinical scenario of Multiple Myeloma"
Claudio Cerchione - New frontiers in overcoming environment mediated drug resistance in AML
Claudio Cerchione - New frontiers in overcoming environment mediated drug resistance in AML
Claudio Cerchione, MD, PhD, Shares Promising Data on Emavusertib in AML #aacr24
Claudio Cerchione, MD, PhD, Shares Promising Data on Emavusertib in AML #aacr24
Environment-mediated drug resistance in AML
Environment-mediated drug resistance in AML
Changing treatment landscape of AML
Changing treatment landscape of AML
Selinexor in the treatment of R/R myeloma: combination strategies and optimizing therapy
Selinexor in the treatment of R/R myeloma: combination strategies and optimizing therapy